Pure Global

“HaemoCer” Haemostatic Powder - Taiwan Registration ebe9c50874bd4bf0f3ab7e874cd9794f

Access comprehensive regulatory information for “HaemoCer” Haemostatic Powder in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number ebe9c50874bd4bf0f3ab7e874cd9794f and manufactured by BIOCER ENTWICKLUNGS-GMBH. The authorized representative in Taiwan is Health Land Inc..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
ebe9c50874bd4bf0f3ab7e874cd9794f
Registration Details
Taiwan FDA Registration: ebe9c50874bd4bf0f3ab7e874cd9794f
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“HaemoCer” Haemostatic Powder
TW: “百歐瑟”止血粉
Risk Class 3
MD

Registration Details

ebe9c50874bd4bf0f3ab7e874cd9794f

Ministry of Health Medical Device Import No. 032360

DHA05603236001

Company Information

Germany

Product Details

For details, it is Chinese approved copy of the imitation order

I General and plastic surgical devices

I4490 Absorbable hemostatic agents and dressings

Imported from abroad

Dates and Status

Apr 01, 2019

Apr 01, 2024